Reagents and Chemicals

Affi-Gel 15

Trypsin

Trypsin inhibitor Yeast extract

Hydroxyapatite Nutrient broth Sephacryl S-300 TRITC-anti rabbit IgG

Agar Noble CM-Sepahdex A-50

Materials

Cooked meat medium

DEAE-Sepahdex A-50 Ficoll 400

Supplier

Bio-Rad

Difco laboratoires

Pharmacia

Difco Laboratories

Pharmacia

Pharmacia

Bio-Rad

Difco Laboratories

Pharmacia

Biosource

International

(Tago Products)

Sigma

Sigma

Difco Laboratories

T 7409 T 9003 527-00305

153-6051

526-00054

17-0220-01

529-00804

17-0180-01

17-0400-01

157-0080

523-00483

17-0599-01

ALI-4406

Cat-No.

References

Bengston IA (1922): Preliminary note on a toxin-producing anaerobe isolated from the larvae of Lucilia caesar. Public Health Rep. 37: 164-170.

Iwasaki M, Ohishi I, Sakaguchi G (1980): Evidence that botulinum C2 toxin has two dissimilar components. Infect. Immun. 29: 390-394.

Jansen BC (1971): The toxic antigenic factors produced by Clostridium botulinum types C and D. Onderstepoort J. Vet. Res. 38: 93-98.

Mason JH, Robinson EM (1935): The antigenic components of the toxins of C. botulinum types C and D. Onderstepoort J. Vet. Sei. Anim. Indus. 5: 65-75.

Miyake M, Ohishi I (1987): Reponse of tissue-cultured cynomolgus monkey kidney cells to botulinum C2 toxin. Microbial Pathogenesis, 3: 279-286.

Ohishi I, Iwasaki M, Sakaguchi G (1980): Purification and characterization of two components of botulinum C2 toxin. Infect. Immun. 30: 668-673.

Ohishi I, Iwasaki M, Sakaguchi G (1980): Vascular permeability activity of botulinum C2 toxin elicited by cooperation of two dissimilar protein components. Infect. Immun. 31: 890-895.

Ohishi I, Sakaguchi G (1982): Production of C2 toxin by Clostridium botulinum types C and D as determined by its vascular permeability activity. Infect. Immun.

Ohishi I (1983): Response of mouse intestinal loop to botulinum C2 toxin: en-terotoxic activity induced by cooperation of nonlinked protein components. Infect, immun. 40: 691-695.

Ohishi I, Tsuyama S (1986): ADP-ribosylation of nonmuscle actin with component I of C2 toxin. Biochem. Biophys. Res. Commun. 136: 802-806.

Ohishi I (1986): NAD-glycohydrolase activity of botulinum C2 toxin: a possible role of component I in the mode of action of the toxin. J. Biochem. 100: 407-413.

Ohishi I (1987): Activation of botulinum C2 toxin by trypsin. Infect. Immun. 55: 1461-1465.

Ohishi I, Morikawa Y, Baba T (1990): ADP-ribosylation of nonmuscle actin by component I of botulinum C2 toxin inactivates the ability to interact with unmodified actin. J. Biochem. 107: 420-425.

Ohishi I (1992): Visualizations of binding and internalization of two nonlinked protein components of botulinum C2 toxin in tissue culture cells. 60: 4648-4655.

Bacterial Toxins

Kletus AKtories

Copyright © 2002 WILEY-VCH Verlag GmbH & Co. KGaA

Anti Aging Made Easy

Anti Aging Made Easy

When it comes to reducing wrinkles, you really have to take your needs seriously. There are a number of factors that play a role in the health and well being of your skin. It is often hard to understand how products work and why they may not work even if they promise to do so. If you are considering wrinkle creams and a regimen of facelifts, you may go broke in the process. Before you do all of that, consider going through a process of determine the very best solution for your needs.

Get My Free Ebook


Post a comment